hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06266741, orgStudyIdInfo id: NCT093509350936, briefTitle: The Predictive Value of Lubricin in Patients With Infective Endocarditis, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2024-02-11, primaryCompletionDateStruct date: 2024-02-20, completionDateStruct date: 2026-02-20, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Aydin Adnan Menderes University, class: OTHER, descriptionModule briefSummary: The main goal of this study is to evaluate the predictability of the disease by measuring the serum lubricin levels in patients with infective endocarditis and in non-patients, conditionsModule conditions: Infective Endocarditis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Lubricin, outcomesModule primaryOutcomes measure: Valve damage indicative sign in infective endocarditis, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Sevil Gulasti, city: Aydın, state: Zafer, zip: 09010, country: Turkey, geoPoint lat: 37.84501, lon: 27.83963, hasResults: False
protocolSection identificationModule nctId: NCT06266728, orgStudyIdInfo id: IRB00006733, briefTitle: T30 for Astigmatism in Digital Device Users, acronym: T30FA, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2024-08-15, completionDateStruct date: 2024-08-18, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Southern College of Optometry, class: OTHER, collaborators name: Alcon Research, descriptionModule briefSummary: This study aims to determine if Total30 lenses for astigmatism can be successfully fit in participants who are heavy digital device users., conditionsModule conditions: Contact Lens Complication, conditions: Astigmatism, conditions: Refractive Errors, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: This prospective, one-month, three-visit study will refit all participants into TOTAL30 for Astigmatism contact lenses., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 48, type: ESTIMATED, armsInterventionsModule interventions name: Total30 for Astigmatism Contact Lenses, outcomesModule primaryOutcomes measure: Visual Analog Scale (VAS) Comfort Scores, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Kannar Eye Care, city: Pittsburg, state: Kansas, zip: 66762, country: United States, geoPoint lat: 37.41088, lon: -94.70496, locations facility: Coldwater VIsion Center, city: Coldwater, state: Mississippi, zip: 38618, country: United States, geoPoint lat: 32.71486, lon: -89.21423, hasResults: False
protocolSection identificationModule nctId: NCT06266702, orgStudyIdInfo id: BL71, briefTitle: Evaluation of a Nutritional Technology for Vitamin D Absorption, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-06, completionDateStruct date: 2024-06, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Abbott Nutrition, class: INDUSTRY, descriptionModule briefSummary: This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption., conditionsModule conditions: Nutrition, Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: OTHER, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 32, type: ESTIMATED, armsInterventionsModule interventions name: Experimental Oil with Phospholipids, interventions name: Control Polyunsaturated Oil Blend, outcomesModule primaryOutcomes measure: Vitamin D Absorption, secondaryOutcomes measure: Vitamin D Absorption - Peak, secondaryOutcomes measure: Vitamin D Absorption - AUC, otherOutcomes measure: Body Mass Index, otherOutcomes measure: Adverse Events, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Walsh University, city: North Canton, state: Ohio, zip: 44720, country: United States, geoPoint lat: 40.87589, lon: -81.40234, hasResults: False
protocolSection identificationModule nctId: NCT06266689, orgStudyIdInfo id: Pro00112671, briefTitle: Project humAn dieTary daTa rEtuRN, acronym: PATTERN, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-12, completionDateStruct date: 2025-12, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Duke University, class: OTHER, descriptionModule briefSummary: This study is designed to test the effects of diet data return on human dietary patterns. The investigators' working hypothesis is that returning diet data, collected via an empirical biomarker-based assessment method, will promote participant eating behavior changes towards a more healthful diet, and that these dietary patterns may also be reflected in the structure and function of the gut microbiome and in participant health outcomes. Here, the investigators will explore this hypothesis with participants supplying stool (poop) samples that will be used to assess their diet using the investigators' DNA-biomarker based method. Participants will have their diet data returned to them, and will then supply post-intervention stool samples for dietary assessment to investigate the efficacy of diet data return in impacting subject dietary patterns and health. It is anticipated that the investigators will enroll infants, children, and adults across the age span, including infants that are currently participating in Project HOPE 1000, a longitudinal observational study of mothers and infants from pregnancy through early childhood (Pro00100000). This study represents a minimal risk to subjects; namely, the potential loss of privacy involved with study participation., conditionsModule conditions: Diet Habit, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 600, type: ESTIMATED, armsInterventionsModule interventions name: Personalized Diet Information, outcomesModule primaryOutcomes measure: Number of participants with diet improvement, primaryOutcomes measure: Number of participants with increased dietary diversity, secondaryOutcomes measure: Number of participants with changes in the composition and function of the gut microbiome, eligibilityModule sex: ALL, maximumAge: 12 Months, stdAges: CHILD, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06266676, orgStudyIdInfo id: 202301775B1, briefTitle: Mobile Micro-course Impact on Perioperative RNs in Heart Surgery Nursing., statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-04-10, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Ting-Fang Yeh, class: OTHER, descriptionModule briefSummary: The goal of this clinical trialis to compare in learning effectiveness of nurses. The main questions it aims to answer are:1. Can the "Micro-course" teaching enhance the awareness of cardiac surgery nursing among operating room nurses?2. Can the "Micro-course" teaching boost the learning motivation and engagement of operating room nurses?3. What is the satisfaction level of nurses regarding the use of "Micro-course" in cardiac surgery nursing?4. What are the relevant factors influencing the effectiveness of the "Micro-course" teaching intervention?Participants will be divided into two groups. The control group will receive online presentations, while the experimental group will engage in mobile learning combined with micro-courses. Both groups of participants will undergo instruction through asynchronous online courses., conditionsModule conditions: periOperative, conditions: Cardiac Surgical Procedures, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 75, type: ESTIMATED, armsInterventionsModule interventions name: micro-course, interventions name: slide presentation, outcomesModule primaryOutcomes measure: Cognitive scale, primaryOutcomes measure: motivation scale, primaryOutcomes measure: Engagement Scale, secondaryOutcomes measure: learning satisfaction, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: ChangGungMH, status: RECRUITING, city: Taoyuan City, zip: 33305, country: Taiwan, contacts name: Ting-Fang Yeh, role: CONTACT, phone: +88633281200, phoneExt: 2380, email: ytf812@cgmh.org.tw, geoPoint lat: 24.95233, lon: 121.20193, hasResults: False
protocolSection identificationModule nctId: NCT06266650, orgStudyIdInfo id: 19485, briefTitle: Unilateral vs Bilateral Application of Muscle Energy Techniques in Pelvic Somatic Dysfunction, acronym: PMEOMT, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2024-08-30, completionDateStruct date: 2024-09-30, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: The Touro College and University System, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to compare the efficacy of pelvic muscle energy technique online against the traditional full length osteopathic pelvic treatment protocol. The main question it aims to answer are• Can one single pelvic muscle energy technique can correct all pelvic somatic dysfunctions (SD)?Participants will* be positioned by the physician into the area of treatment into a position of resistance, which is the restrictive barrier.* be instructed to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce.* be instructed to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier.* These steps are repeated three to five times and then the dysfunction is reevaluated.Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one and be compared with the pelvic muscle energy group., conditionsModule conditions: Pelvic Somatic Dysfunction, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one-sided MET, the second group will be treated with combination MET. Results of post-treatment exams will be collected and statistically analyzed., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Osteopathic Treatment Technique- Muscle Energy Treatment, outcomesModule primaryOutcomes measure: Resolution of pelvic somatic dysfunction, secondaryOutcomes measure: Anterior anatomical landmarks assessment, secondaryOutcomes measure: Posterior anatomical landmarks assessment, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06266637, orgStudyIdInfo id: P.T.REC/012/004999, briefTitle: Effect of Scoliosis-Specific Exercise on Lower Limb Biomechanics, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-03-12, primaryCompletionDateStruct date: 2024-03-01, completionDateStruct date: 2024-03-15, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Delta University for Science and Technology, class: OTHER, collaborators name: Benha University, descriptionModule briefSummary: PURPOSE: To examine the effect of Physiotherapeutic Scoliosis-Specific Exercise on limb biomechanical parameters in adolescents with idiopathic scoliosis. A randomised controlled trialBACKGROUND:Adolescent idiopathic scoliosis is one of the most common orthopaedic diseases affecting the spine during adolescence. The efficacy of exercise treatment is controversial. Although evidence suggests that PSSE, which include auto-correction in 3D, integration in daily life, stabilizing the corrected posture, and patient education, could improve some outcomes, effect of PSSE on related biomechanical alterations in lower limbs have not yet been examined.HYPOTHESES:Null hypothesis There are no statistically significant effect of Physiotherapeutic Scoliosis-Specific Exercise on lower limb biomechanics in scoliotic adolescents.RESEARCH QUESTION:What are the effect of Physiotherapeutic Scoliosis-Specific Exercise on lower limb biomechanics in scoliotic adolescents.?, conditionsModule conditions: Scoliosis Idiopathic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 56, type: ACTUAL, armsInterventionsModule interventions name: Conventional Physical Therapy Program, interventions name: Physiotherapeutic Scoliosis-Specific Exercise (Schroth), outcomesModule primaryOutcomes measure: Cobb's angle, primaryOutcomes measure: Coronal balance, primaryOutcomes measure: length of the the tibia and femur, primaryOutcomes measure: tibiofemoral angle, primaryOutcomes measure: knee joint line convergence angle, primaryOutcomes measure: lower limb mechanical axis; and mechanical axis deviation, eligibilityModule sex: ALL, minimumAge: 10 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Delta university for science and technology, city: Gamasa, state: Dakahleya, zip: 7731168, country: Egypt, geoPoint lat: 31.44112, lon: 31.53675, hasResults: False
protocolSection identificationModule nctId: NCT06266624, orgStudyIdInfo id: Tourniquet in HHT, briefTitle: Tourniquet-Test in HHT, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2020-09-25, primaryCompletionDateStruct date: 2023-07-30, completionDateStruct date: 2024-07-30, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: University Hospital, Essen, class: OTHER, descriptionModule briefSummary: The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT., conditionsModule conditions: HHT, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 92, type: ACTUAL, armsInterventionsModule interventions name: Tourniquet Test, outcomesModule primaryOutcomes measure: number of positive Tourniquet Test results in HHT patients, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hospital Essen, city: Essen, state: Nordrhein Westphalen, zip: 45122, country: Germany, geoPoint lat: 51.45657, lon: 7.01228, hasResults: False
protocolSection identificationModule nctId: NCT06266598, orgStudyIdInfo id: EU-TF-HA-01, briefTitle: Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-11-17, primaryCompletionDateStruct date: 2021-08-20, completionDateStruct date: 2021-10-27, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: HÜMEYRA ACIKAN, class: OTHER, descriptionModule briefSummary: In our study, there are 33 healthy children with normal weight (control group) and 52 obese children who will be treated with metformin. To observe the efficacy of the 3-month treatment before and after metformin treatment, Zn, Zinc α-2 Glycoprotein (ZAG), Peroxisome proliferation activating receptor γ (PPARγ), Leptin (LEP) and Adiponectin (ADIPO) levels were compared, as well as anthropometric measurements and routine biochemistry tests., conditionsModule conditions: Childhood Obesity, conditions: Insulin Resistance, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: In our study, there are 33 healthy children with normal weight (control group) and 52 obese children who will be treated with metformin. To observe the efficacy of the 3-month treatment before and after metformin treatment, Zn, Zinc α-2 Glycoprotein (ZAG), Peroxisome proliferation activating receptor γ (PPARγ), Leptin (LEP) and Adiponectin (ADIPO) levels were compared, as well as anthropometric measurements and routine biochemistry tests., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 52, type: ACTUAL, armsInterventionsModule interventions name: Metformin, outcomesModule primaryOutcomes measure: Insulin resistance (HOMA-IR) level, primaryOutcomes measure: Weight loss rate, eligibilityModule sex: ALL, minimumAge: 9 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Erciyes University, city: Kayseri̇, state: Melikgazi, zip: 38030, country: Turkey, geoPoint lat: 38.73222, lon: 35.48528, hasResults: False
protocolSection identificationModule nctId: NCT06266585, orgStudyIdInfo id: HX-B-2023090, briefTitle: Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-01-01, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2024-01-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Beijing Tiantan Hospital, class: OTHER, collaborators name: Beijing Chao Yang Hospital, collaborators name: Beijing Friendship Hospital, descriptionModule briefSummary: The objective of this retrospective, prospective, multicenter cohort study is to determine the risk factors for deterioration of CVT patients after admission and establish a scoring model for risk stratification of patients. This study included two stages, the first stage was to enroll CVT patients from a single center from 2017 to 2022 for modeling, and the second stage was to enroll CVT patients from three centers in 2023 for external validation, conditionsModule conditions: Cerebral Venous Thrombosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 273, type: ACTUAL, outcomesModule primaryOutcomes measure: Number of Participants with CVT deteriorated on radiology, primaryOutcomes measure: Number of Participants with altered neurological function, primaryOutcomes measure: Number of Participants with altered consciousness, secondaryOutcomes measure: Neurological function at 30th day after onset (mRS), secondaryOutcomes measure: Emergency surgery rates, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Capital Medical University Affiliated Beijing Tiantan Hospital, city: Beijing, state: Beijing, country: China, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06266572, orgStudyIdInfo id: 1R43DA055182-01, type: NIH, link: https://reporter.nih.gov/quickSearch/1R43DA055182-01, briefTitle: Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment, acronym: OASIS, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-09-30, primaryCompletionDateStruct date: 2023-09-29, completionDateStruct date: 2023-09-29, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Center for Social Innovation, Massachusetts, class: OTHER, descriptionModule briefSummary: C4 Innovations (C4) and partners at Yale University (Yale) and the West Haven VA Medical Center (WHVA) proposed to develop and test OASIS (Overcoming and Addressing Stigma in Substance Use Disorders), a web-based educational platform for primary care clinicians and individuals with Opioid Use Disorder. The major aims of the study were to:1. Develop a prototype of OASIS for patients with Opioid Use Disorder (OUD) and primary care clinicians; conduct usability testing.2. Pilot OASIS with a small sample of individuals with untreated OUD and their clinicians to determine feasibility, acceptability, and preliminary product effectiveness for a Phase II effectiveness trial.After development of the prototype, the C4-Yale-WHVA team planned to test OASIS with patients (N = 30) and clinicians (N = 5) using validated measures and qualitative interviews to assess usability, satisfaction, knowledge, empowerment, and stigma., conditionsModule conditions: Opioid Use Disorder, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 19, type: ACTUAL, armsInterventionsModule interventions name: Overcoming and Addressing Stigma in Substance Use Disorders (OASIS), outcomesModule primaryOutcomes measure: Open Minds Scale for Health Care Providers, primaryOutcomes measure: Brief Opioid Stigma Scale, primaryOutcomes measure: Perceived Stigma of Addiction Scale, primaryOutcomes measure: Knowledge Check, primaryOutcomes measure: System Usability Scale, primaryOutcomes measure: Internalized Stigma of Mental Illness Scale, primaryOutcomes measure: Recovery Empowerment Scale, primaryOutcomes measure: Mental Health Seeking Attitudes Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: West Haven VA Medical Center, city: West Haven, state: Connecticut, zip: 06516, country: United States, geoPoint lat: 41.27065, lon: -72.94705, hasResults: False